INSIGHTS ON DRUG DEVELOPMENT
-
Cell Cycle Mapping In Tumors With Advanced Technologies
Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.
-
Analyzing Biological Drug Effects In 3D
Explore how 3D tumor microtissues paired with fluorescence-based assays offer scalable, high-sensitivity drug testing to deliver stronger signals and reproducible results compared to monolayer cultures.
-
Maximizing Laboratory Efficiency With Automated Dual-Thermal Cycling
Accelerate tRNA lead discovery with automated digital PCR. Process 384 samples daily with minimal hands-on time, using dual thermal cyclers to scale from in vitro screening to clinical trials.
-
Denaturing SEC-MS Analysis Of High Molecular Weight Impurities
Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.
-
Spray Dried Dispersions In Controlled Release Formulations10/16/2025
Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation.
-
Developing A Quantitative Surrogate Peptide Assay7/17/2025
Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.
-
Nasal Delivery: Strategies For Success3/2/2026
A strengthened partnership enhances manufacturing for an ultra‑rare disease therapy, leveraging advanced containment upgrades to improve safety, reliability, capacity, and maintain global patient access.
-
A Case Study Of The GLP-1 Receptor Agonist, Semaglutide, In Plasma7/31/2025
Light scattering reveals critical insights into the structural integrity, aggregation, and stability of GLP-1 analogs, which are essential for optimizing drug formulations and improving treatments.
-
How To Avoid Sticking And Picking In The Tableting Industry9/23/2024
Review strategies to mitigate sticking and picking risks in the tablet industry, and learn how you can foster improved tablet production processes, ensuring higher quality and consistency.
DRUG DEVELOPMENT SOLUTIONS
-
Discover the benefits of partnering with a CDMO that offers expanding capacity and capabilities and a far-reaching operational footprint to support your project.
-
See how integrated analytical capabilities help improve visibility across mAb workflows, enabling faster decisions, stronger process control, and reliable quality outcomes from development through QC.
-
See More with Microflow LC-MS
The M5 MicroLC system is the perfect balance of sensitivity and robustness—more sensitive than traditional analytical flow LC, and more flexible and more robust than nanoflow LC — giving you the potential to optimize your critical workflows, today and into the future.
-
Explore a wide variety of DHR temperature systems and accessories, designed for superior performance and ease-of-use.
-
Natoli’s line of affordable tablet presses is designed, engineered, and manufactured in the U.S.A. and built on our decades of experience in the tableting industry. We know our customers want presses that efficiently meet their R&D and/or production needs.
With Natoli you have a choice in your tablet press: R&D or production, single-station or rotary, fully automated or manual. Whatever your need, Natoli’s best-in-class tablet presses can help you optimize tablet quality while saving time and reducing costs.